Dyadic International, Inc.: Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development

Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development. LIANYUNGANG, CHINA and JUPITER, FL / ACCESSWIRE / August 17, 2020 / Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further applying its….


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.